Galluppi Stefan 4/A
4/A · LifeMD, Inc. · Filed May 31, 2023
Insider Transaction Report
Form 4/AAmended
LifeMD, Inc.LFMD
Galluppi Stefan
Chief Innovation Officer
Transactions
- Purchase
Common Stock, par value $0.01
2023-05-23$2.17/sh+4,608$9,999→ 12,449 total
Holdings
- 1,644,800(indirect: By LLC)
Common Stock, par value $0.01
Footnotes (1)
- [F1]This Form 4 corrects the number of shares purchased.